Position in ABBV
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$5,872,774
+$1,212,834 QoQ
Shares Held
23,338
+8.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#1,215
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trilogy Capital Inc. holds $25,279,882 across 7 Drug Manufacturers - General names. ABBV ranks #2 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,952 | $7,139,007 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
23,338 | $5,872,774 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
41,026 | $5,183,224 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,029 | $5,143,726 | |
| 5 | JNJ |
Johnson & Johnson
|
5,109 | $1,297,532 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,935 | $341,974 | |
| 7 | AMGN |
Amgen Inc
|
833 | $301,645 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,872,774 | 23,338 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $4,659,940 | 21,426 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $4,797,376 | 20,996 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $4,917,214 | 21,237 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $4,009,392 | 21,600 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $4,629,134 | 22,094 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,811,924 | 15,824 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $897,151 | 4,543 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $805,114 | 4,694 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $868,070 | 4,767 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $3,047,949 | 19,668 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,960,629 | 19,862 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,660,243 | 19,745 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $3,025,480 | 18,984 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $2,573,800 | 15,926 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,830,221 | 13,637 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $1,840,830 | 12,019 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,022,970 | 12,479 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $1,433,750 | 10,589 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,093,370 | 10,136 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,138,452 | 10,107 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $845,955 | 7,817 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $702,582 | 6,557 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $567,057 | 6,474 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $670,962 | 6,834 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $533,710 | 7,005 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||